Corneal Cross-linking for Progressive Keratoconus
This study is looking at the safety and effectiveness of different levels of NXL Energy treatments for people with progressive keratoconus, a condition where your cornea (the clear front part of your eye) thins and bulges. The NXL Energy treatments involve special riboflavin drops and a system that delivers energy. Some participants will receive a sham treatment, which means they get sham drops and no energy exposure. Researchers want to see if these treatments can improve your eye's shape, measured by topography, after 12 months. You might be able to join if you are between 18 and 55 years old, have keratoconus, and can follow study instructions. The study plans to enroll 150 people, but its current status is unclear.
- Study design
- This is a multi-center study that compares different doses of NXL Energy treatments to a sham treatment. It plans to include 150 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your eye's shape will be measured at 12 months after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
At a glance
Conditions
Where it's being run
3 sites across 3 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Topography12 Months
Change in Kmax topography value from baseline